GR3035725T3 - Polyamine compounds for treating vascular proliferative disorders - Google Patents

Polyamine compounds for treating vascular proliferative disorders

Info

Publication number
GR3035725T3
GR3035725T3 GR20010400577T GR20010400577T GR3035725T3 GR 3035725 T3 GR3035725 T3 GR 3035725T3 GR 20010400577 T GR20010400577 T GR 20010400577T GR 20010400577 T GR20010400577 T GR 20010400577T GR 3035725 T3 GR3035725 T3 GR 3035725T3
Authority
GR
Greece
Prior art keywords
proliferative disorders
polyamine compounds
vascular proliferative
treating vascular
treating
Prior art date
Application number
GR20010400577T
Other languages
English (en)
Inventor
Donald Hupe
Joan Alexis Keiser
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of GR3035725T3 publication Critical patent/GR3035725T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR20010400577T 1994-10-25 2001-04-06 Polyamine compounds for treating vascular proliferative disorders GR3035725T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/329,588 US5516807A (en) 1994-10-25 1994-10-25 Method for treating vascular proliferative disorders following balloon angioplasty
PCT/US1995/011680 WO1996012480A1 (en) 1994-10-25 1995-09-14 Polyamine compounds for treating vascular proliferative disorders

Publications (1)

Publication Number Publication Date
GR3035725T3 true GR3035725T3 (en) 2001-07-31

Family

ID=23286110

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400577T GR3035725T3 (en) 1994-10-25 2001-04-06 Polyamine compounds for treating vascular proliferative disorders

Country Status (12)

Country Link
US (1) US5516807A (el)
EP (1) EP0786991B1 (el)
JP (1) JPH10507752A (el)
AT (1) ATE198706T1 (el)
CA (1) CA2198914A1 (el)
DE (1) DE69519937T2 (el)
DK (1) DK0786991T3 (el)
ES (1) ES2155531T3 (el)
GR (1) GR3035725T3 (el)
MX (1) MX9701838A (el)
PT (1) PT786991E (el)
WO (1) WO1996012480A1 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
ATE377418T1 (de) 1995-06-07 2007-11-15 Poniard Pharmaceuticals Inc Vorbeugung und behandlung von kardiovaskulären beschwerden mit tamoxifen-analogen
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
DE69733207T2 (de) * 1996-09-13 2006-02-02 University of Florida Research Foundation, Inc., Gainesville Verfahren zur hemmung von elf5a-biosynthese
US6083991A (en) * 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment
US7087648B1 (en) 1997-10-27 2006-08-08 The Regents Of The University Of California Methods for modulating macrophage proliferation using polyamine analogs
US8198334B2 (en) * 1997-10-27 2012-06-12 Pathologica Llc Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
AU4678300A (en) * 1999-04-30 2000-11-17 Slil Biomedical Corporation Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
US6649587B1 (en) 1999-04-30 2003-11-18 Slil Biomedical Corporation Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
JP4743673B2 (ja) * 1999-04-30 2011-08-10 プロゲン ファーマシューティカルズ, インコーポレイテッド ポリアミンおよび治療におけるそれらの使用
US6482943B1 (en) * 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
AU2001297817A1 (en) * 2000-11-08 2002-11-25 Eli Lilly And Company Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
MXPA04005509A (es) 2001-12-07 2004-12-06 Slil Biomedical Corp Poliaminas sustituidas con cicloalquilo para terapia de cancer y metodos de sintesis de las mismas.
JP2004189714A (ja) * 2002-12-09 2004-07-08 Rasanen Tiina-Liisa すい臓炎の治療と予防ならびに肝臓再生機能の誘導のための薬剤
MX2007004030A (es) * 2004-10-04 2008-01-14 Cellgate Inc Analogos de poliamina como agentes terapeuticos para enfermedades oculares.
WO2007106554A2 (en) * 2006-03-14 2007-09-20 Progen Pharmaceuticals, Inc. Treatment and prevention of vascular hyperplasia using polyamine and polyamine analog compounds
US8709419B2 (en) * 2010-08-17 2014-04-29 Hoffmann-La Roche, Inc. Combination therapy
US9295669B2 (en) 2010-12-14 2016-03-29 Hoffman La-Roche Inc. Combination therapy for proliferative disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606348B2 (ja) * 1976-03-31 1985-02-18 三菱化学株式会社 新規ポリアミン類
JPS58135809A (ja) * 1982-02-05 1983-08-12 Fujisawa Pharmaceut Co Ltd 抗炎症・抗リウマチ剤
US4507321A (en) * 1982-02-17 1985-03-26 The Research Foundation Of State University Of New York Epithelial cell growth regulating composition containing polyamines and a method of using same
JPS606348A (ja) * 1983-06-09 1985-01-14 ケルベル・アクチエンゲゼルシヤフト 回転研削工具の支承装置
NZ212053A (en) * 1984-05-17 1988-02-29 Merrell Dow Pharma Polyamine containing pharmaceutical compositions for treating neoplasms
US5091576A (en) * 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
NZ223340A (en) * 1987-02-03 1991-03-26 Merrell Dow Pharma Polyamine derivatives and pharmaceutical compositions
ZA903804B (en) * 1989-05-23 1991-03-27 Merrell Dow Pharma A method of potentiating cell-mediated immunity utilizing polyamine derivatives

Also Published As

Publication number Publication date
EP0786991A1 (en) 1997-08-06
WO1996012480A1 (en) 1996-05-02
DE69519937D1 (de) 2001-02-22
DK0786991T3 (da) 2001-03-19
DE69519937T2 (de) 2001-06-07
ES2155531T3 (es) 2001-05-16
US5516807A (en) 1996-05-14
PT786991E (pt) 2001-04-30
CA2198914A1 (en) 1996-05-02
ATE198706T1 (de) 2001-02-15
MX9701838A (es) 1997-06-28
EP0786991B1 (en) 2001-01-17
JPH10507752A (ja) 1998-07-28

Similar Documents

Publication Publication Date Title
GR3035725T3 (en) Polyamine compounds for treating vascular proliferative disorders
HU9502587D0 (en) Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation
PL323916A1 (en) Imidazolic compounds
AU2597292A (en) Method and apparatus for restenosis treatment
EP0817791A4 (en) VIRAL VECTORS AND THEIR USE TO TREAT HYPERPROLIFERATIVE DISEASES, IN PARTICULAR RESTENOSIS
NZ332780A (en) Substituted amines for the treatment of neurological and neuropsychiatric disorders
PL320169A1 (en) 6-arylpyrido [2,3-d] pyrimidines and naphtyridines for inhibiting thyrosine kinase protein being instrumental in cellular proliferation
ZA96528B (en) 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders
EP0830178A4 (en) METHOD AND DEVICE FOR TREATING VASCULAR TISSUE AFTER ANGIOPLASTY TO MINIMIZE THE RESIDUAL RISK
PL313349A1 (en) Method of diagnoasing, progdnosticating and treating non-lymphatic tumours and their metastases
AU3131697A (en) Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
PL330496A1 (en) Methods of and compositions for treating and preventing tumours, disorders associated with tumours as well as cachexy
EP0730449A4 (en) NOVEL PALLADIUM COMPLEXES AND METHODS OF USE THEREOF IN THE TREATMENT OF TUMORS AND PSORIASIS
MY141670A (en) Material and method for treatment of timber
MXPA01011923A (es) Composiciones y metodos para tratar alteraciones en la proliferacion celular.
TW282455B (el)
EP0739996A3 (en) Surface treating agent for plating and base material with the plating adhered thereto
EP0888780A4 (en) COMPOSITION FOR TREATING CONTACT LENSES AND METHOD FOR USE THEREOF
UA41915C2 (uk) Засіб для інгібування проліферації і міграції клітин васкулярних гладенькіх м`язів у ссавців
ZA200101188B (en) DNAzymes and methods for treating restenosis.
NZ332590A (en) Process and apparatus for treating leather and the like
ZA929156B (en) A process and composition for treating the surface of tinplated steel.
EP0608906A3 (en) Apparatus and method for treating hosiery articles.
EP0708638A4 (en) METHODS AND COMPOSITIONS FOR TREATING DEPRESSION AND OTHER PSYCHIATRIC DISEASES
ZA932956B (en) Substrate treatment method and apparatus.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees